Home β€Ί Stock analysis β€Ί ICU

SeaStar Medical (ICU) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

ICU rises 1.7% to $3.06. Closed at $3.06, +1.66% vs the prior close of $3.01. Day range $2.89–$3.13, opened at $3.01.

Last close$3.06+1.66%
Day range2.89–3.13
Open3.01
Volume206.30K
52-week range2.07–7.35
Avg volume (20d)223.26K

ICU daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 β€” ICU rises 1.7% to $3.06
Oct 14, 2026 β€” ICU slides 16.2% to $3.01, a 1-month low on 4.4x normal volume
Oct 13, 2026 β€” ICU slides 6.8% to $3.59
Oct 12, 2026 β€” ICU jumps 6.6% to $3.85
Oct 9, 2026 β€” ICU jumps 3.4% to $3.61
Oct 8, 2026 β€” ICU slides 6.2% to $3.49 on 1.9x normal volume
Oct 7, 2026 β€” ICU jumps 16.6% to $3.72 on 16.7x normal volume
Oct 6, 2026 β€” ICU slides 10.1% to $3.19 on 3.8x normal volume
Oct 5, 2026 β€” ICU slides 24.3% to $3.55 on 8.9x normal volume
Oct 2, 2026 β€” ICU jumps 25.1% to $4.69, a 1-month high on 9.0x normal volume

ICU latest news & SEC filings

Every SEC filing by or about ICU in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 8, 2026 Β· Form D β€” D filing

D filing

Source: SEC EDGAR filing 0001831868-26-000002

Oct 5, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001437749-26-032035

Aug 19, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001437749-26-028540

Aug 12, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001437749-26-027353

Aug 12, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001437749-26-027314

Jul 21, 2026 Β· Form S-8 β€” Employee share plan registration

Registration of shares for employee stock plans (S-8)

Source: SEC EDGAR filing 0001437749-26-023943

Jul 2, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001437749-26-022573

Jul 2, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001437749-26-022569

Jul 2, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001437749-26-022567

Jul 2, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001437749-26-022566

Jul 2, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001437749-26-022565

Jul 1, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001437749-26-022278

Jun 23, 2026 Β· Form 8-K/A β€” Current report (amended)

Amended current report

Source: SEC EDGAR filing 0001437749-26-021441

Things to know before you trade ICU

ICU market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 15, 20263.013.132.893.06206.30K
Oct 14, 20263.593.622.873.01502.60K
Oct 13, 20263.883.923.503.59124.80K
Oct 12, 20263.553.953.513.85116.10K
Oct 9, 20263.573.633.313.61104.40K
Oct 8, 20263.593.723.333.49209.10K
Oct 7, 20263.263.773.053.721.36M
Oct 6, 20263.483.503.073.19292.70K
Oct 5, 20263.623.743.443.55593.90K
Oct 2, 20263.784.803.684.69515.60K
Oct 1, 20263.993.993.713.7528.30K
Sep 30, 20263.624.093.623.9486.70K
Sep 29, 20263.403.753.263.56135.10K
Sep 28, 20263.423.423.333.4010.40K
Sep 25, 20263.483.543.393.4230.00K
Sep 24, 20263.453.513.223.4413.90K
Sep 23, 20263.553.603.453.5311.50K
Sep 22, 20263.583.603.423.5322.10K
Sep 21, 20263.573.583.333.5822.50K
Sep 18, 20263.513.683.433.5477.80K

About SeaStar Medical

SeaStar Medical (ICU) is listed on the Nasdaq and classified by the SEC under β€œSurgical & Medical Instruments & Apparatus”. Its business address is in DENVER, CO. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1831868.

ICU board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Jennifer A BairdDirectorJul 2, 2026
John NeumanDirectorJul 2, 2026
Heel Kenneth VanDirectorJul 2, 2026
Bernadette N VincentDirectorJul 2, 2026

Executive officers

NameTitleLatest filing
Kevin ChungChief Medical OfficerJul 2, 2026
Michael MessingerChief Financial OfficerAug 19, 2026
Eric SchlorffChief Executive OfficerJul 2, 2026
Bradford K TownePrincipal Accounting OfficerFeb 10, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Aug 18, 2026Michael MessingerBuy750$3.27
Dec 19, 2025Jennifer A BairdBuy4,200$0.24
Dec 9, 2025Michael MessingerBuy14,500$0.35

ICU financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$1.23M$-12.15Mβ€”$-13.60M
Dec 31, 2024$135.00K$-24.83M-6.63$-16.01M
Dec 31, 2023$0$-26.23M-30.26$-10.29M
Dec 31, 2022β€”$-12.19M-1.48$-7.79M
Dec 31, 2021β€”$-4.60M-0.63$-5.11M

Latest balance sheet: total assets $8.65M, total liabilities $4.35M, cash $51.57K (as of Jun 30, 2026).

ICU earnings / results-day log

DateFilingClose that day
Aug 12, 20268-K Item 2.02 (results)$3.36
May 13, 20268-K Item 2.02 (results)$4.60
Mar 25, 20268-K Item 2.02 (results)$2.28
Nov 13, 20258-K Item 2.02 (results)$4.60
May 14, 20258-K Item 2.02 (results)$12.30
Mar 27, 20258-K Item 2.02 (results)$22.00
Nov 13, 20248-K Item 2.02 (results)$25.20
May 14, 20248-K Item 2.02 (results)β€”
Apr 17, 20248-K Item 2.02 (results)β€”
Nov 22, 20238-K Item 2.02 (results)β€”
Aug 15, 20238-K Item 2.02 (results)β€”
May 16, 20238-K Item 2.02 (results)β€”

Related stocks Β· Surgical & Medical Instruments & Apparatus

Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)

Popular today

Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)

More on ICU

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.